Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-04

Clinical Trial Update: A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Botensilimab and Balstilimab for metastatic colorectal cancer is currently active but not recruiting, sponsored by Agenus Inc. This u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Balstilimab (balstilimab)
  • Botensilimab (botensilimab)

Snippet

Sponsor: Agenus Inc. | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING